Reckitt Benckiser Group (LON:RKT – Get Free Report) issued its quarterly earnings results on Friday. The company reported GBX 147.08 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Reckitt Benckiser Group had a net margin of 22.40% and a return on equity of 45.27%.
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group stock opened at GBX 4,984.16 on Friday. The stock has a market cap of £31.65 billion, a P/E ratio of 10.24, a P/E/G ratio of 1.10 and a beta of 0.25. The company has a quick ratio of 0.46, a current ratio of 0.85 and a debt-to-equity ratio of 108.83. The company’s 50 day moving average price is GBX 4,706.82 and its two-hundred day moving average price is GBX 5,378.55. Reckitt Benckiser Group has a 52 week low of GBX 3,866 and a 52 week high of GBX 6,522.92.
Insider Activity at Reckitt Benckiser Group
In other Reckitt Benckiser Group news, insider Marybeth Hays purchased 340 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The shares were bought at an average cost of GBX 4,585 per share, for a total transaction of £15,589. Also, insider Deepak Nath bought 257 shares of the stock in a transaction on Tuesday, June 23rd. The shares were acquired at an average cost of GBX 4,650 per share, for a total transaction of £11,950.50. Over the last three months, insiders have acquired 1,029 shares of company stock worth $21,416,350. 0.44% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
View Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- PepsiCo’s Dividend Could Turn Patience Into Real Profit
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
